Author:
Kreher U.,Darius J.,Wien F.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. Pisani F. (1992): Influence of co-medication on the metabolism of valproate. Pharm Weekblad Scientific edition, 14, 108–113.
2. Nau H., Siemes H., Fisher E., Pund R., Wittfoht W., Drews E. (1991): Valproic acid metabolite patterns in 195 children with epilepsy: Effect of age, dose, comedication, duration of treatment, and clinical factors. In: Levy R.H., Penry J.K. eds. Idiosyncratic reactions to valproate: Clinical risk patterns and mechanisms of toxicity. New York: Raven Press, 65–74.
3. Fisher E., Siemes H., Pund R., Wittfoht W., Nau H. (1992): Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: Abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia, 33, 165–171.
4. Eadie M.J., Hooper W.D., Dickinson R.G. (1988): Valproate-associated hepatotoxicity and its biochemical mechanism. Med Toxicol, 3, 85–106.
5. Anderson G.D., Acheampong A.A., Wilensky A.J., Levy R.H. (1992): Effect of valproate dose on formation of hepatotoxic metabolites. Epilepsia, 33, 736–742.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献